Adding Camrelizumab to Chemo Improves OS in Advanced Squamous NSCLC

Adding camrelizumab to chemotherapy prolonged overall survival in patients with advanced squamous non-small cell lung cancer.

Related Keywords

China ,Shanghai ,Caicun Zhou ,European Lung Cancer Congress ,Jiangsu Hengrui Pharmaceuticals Co Ltd ,Lung Cancer Congress ,Shanghai Pulmonary Hospital ,